An agreement was concluded with Italian pharmaceutical company Italfarmaco for the procurement of the drug Givinostat, intended for patients with Duchenne muscular dystrophy [DMD]. Such a statement made today the Minister of Health.

As he noted, Georgia will be among the first countries in the world to procure the medication and integrate it into the state disease management program.

"Regarding the medication for DMD, I can inform you that negotiations with the Italian company Italfarmaco were successfully concluded today, with an agreement signed for the procurement of the drug Givinostat. This medication is designated for patients with DMD from the age of 6 until the loss of ambulation. It should be noted that Georgia will be among the first countries in the world to purchase this drug and incorporate it into its state disease management program. I wish to express my gratitude to the parents who assisted the state in making the right decision. Continued collaboration with parents remains vital for the Ministry in effectively managing DMD.

I want to thank the Prime Minister for his decision and personal involvement, which made it possible to steer this process to a successful conclusion. I also extend my thanks to the Foreign Ministry for their exceptional support, as well as to the Health Ministry team involved in the negotiation process.

As for the 2nd medication previously discussed, negotiations on several fronts remain ongoing. Hope, they will reach a successful conclusion in the near future, at which point we will naturally share details with the public. Over the coming days, we will also provide further information regarding the upcoming expansion of the DMD programme", -said Mikheil Sarjveladze.